BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 8513277)

  • 1. Alterations of retinoblastoma susceptible gene accompanied by c-myc amplification in human bone and soft tissue tumors.
    Ozaki T; Ikeda S; Kawai A; Inoue H; Oda T
    Cell Mol Biol (Noisy-le-grand); 1993 Mar; 39(2):235-42. PubMed ID: 8513277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the retinoblastoma gene in primary osteosarcomas and other bone and soft-tissue tumors.
    Araki N; Uchida A; Kimura T; Yoshikawa H; Aoki Y; Ueda T; Takai S; Miki T; Ono K
    Clin Orthop Relat Res; 1991 Sep; (270):271-7. PubMed ID: 1884549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic alterations in sarcomas: a histologic correlative study with use of oncogene panels.
    Maillet MW; Robinson RA; Burgart LJ
    Mod Pathol; 1992 Jul; 5(4):410-4. PubMed ID: 1495946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sporadic amplification of the MYC gene in human osteosarcomas.
    Ladanyi M; Park CK; Lewis R; Jhanwar SC; Healey JH; Huvos AG
    Diagn Mol Pathol; 1993 Sep; 2(3):163-7. PubMed ID: 8287230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification of c-myc oncogene and absence of c-Ha-ras point mutation in human bone sarcoma.
    Barrios C; Castresana JS; Ruiz J; Kreicbergs A
    J Orthop Res; 1993 Jul; 11(4):556-63. PubMed ID: 8101872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification of the gli gene in childhood sarcomas.
    Roberts WM; Douglass EC; Peiper SC; Houghton PJ; Look AT
    Cancer Res; 1989 Oct; 49(19):5407-13. PubMed ID: 2766305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification of the c-myc proto-oncogene in human chondrosarcoma.
    Castresana JS; Barrios C; Gómez L; Kreicbergs A
    Diagn Mol Pathol; 1992 Dec; 1(4):235-8. PubMed ID: 1342971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of oncogene, tumor suppressor gene, and chromosomal alterations in HeLa x osteosarcoma somatic cell hybrids.
    Isfort RJ; Cody DB; Lovell GJ; Gioeli D; Weissman BE; Doersen CJ
    Mol Carcinog; 1999 May; 25(1):30-41. PubMed ID: 10331742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 gene gets altered by various mechanisms: studies in childhood sarcomas and retinoblastoma.
    Ghule P; Kadam PA; Jambhekar N; Bamne M; Pai S; Nair C; Banavali S; Puri A; Agarwal M
    Med Sci Monit; 2006 Dec; 12(12):BR385-396. PubMed ID: 17136003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas.
    Mousses S; McAuley L; Bell RS; Kandel R; Andrulis IL
    Mod Pathol; 1996 Jan; 9(1):1-6. PubMed ID: 8821948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
    Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M
    Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation spectrum of the retinoblastoma gene in osteosarcomas.
    Wadayama B; Toguchida J; Shimizu T; Ishizaki K; Sasaki MS; Kotoura Y; Yamamuro T
    Cancer Res; 1994 Jun; 54(11):3042-8. PubMed ID: 8187094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant fibrous histiocytoma of bone: analysis of genomic imbalances by comparative genomic hybridisation and C-MYC expression by immunohistochemistry.
    Tarkkanen M; Larramendy ML; Böhling T; Serra M; Hattinger CM; Kivioja A; Elomaa I; Picci P; Knuutila S
    Eur J Cancer; 2006 May; 42(8):1172-80. PubMed ID: 16630715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation.
    Kanoe H; Nakayama T; Murakami H; Hosaka T; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Sasaki MS; Toguchida J
    Anticancer Res; 1998; 18(4A):2317-21. PubMed ID: 9703873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytogenetics in pediatric solid tumors].
    Kaneko Y
    Rinsho Byori; 1990 Sep; 38(9):1047-52. PubMed ID: 2172598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cellular biology of bone tumors.
    Womer RB
    Clin Orthop Relat Res; 1991 Jan; (262):12-21. PubMed ID: 1984907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sporadic amplification of the c-fms proto-oncogene in human musculoskeletal sarcomas.
    Castresana JS; Barrios C; Ruiz J; Gómez L; Kreicbergs A
    Anticancer Res; 1993; 13(3):807-10. PubMed ID: 8317916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of c-onc genes in choriocarcinoma cells].
    Fujino T
    Hokkaido Igaku Zasshi; 1987 Sep; 62(5):798-807. PubMed ID: 3692432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SAS is amplified predominantly in surface osteosarcoma.
    Noble-Topham SE; Burrow SR; Eppert K; Kandel RA; Meltzer PS; Bell RS; Andrulis IL
    J Orthop Res; 1996 Sep; 14(5):700-5. PubMed ID: 8893761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytogenetic data on sarcomas of the bone and soft tissue].
    Aurias A
    Bull Cancer; 1988; 75(5):423-9. PubMed ID: 3165034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.